Symbols / MGRX $0.39 -4.33%
MGRX Chart
About
Mangoceuticals, Inc. engages in the development, marketing, and sale of various men's wellness products and services through a telemedicine platform in the United States. The company offers erectile dysfunction products under the Mango brand; hair loss products under the Grow brand; hormone balance and therapy products under the Mojo brand; and weight loss products under the Slim brand. It also provides oral testosterone undecanoate to treat low testosterone in men and as a form of testosterone replacement therapy under the Prime brand; and access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations. The company markets and sells its products online through its website www.MangoRX.com. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Health Information Servi | Market Cap | 6.30M |
| Enterprise Value | 5.25M | Income | -20.77M | Sales | 466.91K |
| Book/sh | 1.13 | Cash/sh | 0.04 | Dividend Yield | — |
| Payout | 0.00% | Employees | 3 | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | 13.48 | P/B | 0.34 | P/C | — |
| EV/EBITDA | -0.32 | EV/Sales | 11.24 | Quick Ratio | 0.60 |
| Current Ratio | 0.74 | Debt/Eq | 0.71 | LT Debt/Eq | — |
| EPS (ttm) | -2.72 | EPS next Y | — | EPS Growth | — |
| Revenue Growth | -36.80% | Earnings | — | ROA | -73.78% |
| ROE | -136.16% | ROIC | — | Gross Margin | 60.62% |
| Oper. Margin | -89.14% | Profit Margin | 0.00% | Shs Outstand | 16.29M |
| Shs Float | 9.14M | Short Float | 12.01% | Short Ratio | 0.10 |
| Short Interest | — | 52W High | 5.20 | 52W Low | 0.33 |
| Beta | 2.33 | Avg Volume | 7.60M | Volume | 196.34K |
| Target Price | — | Recom | None | Prev Close | $0.40 |
| Price | $0.39 | Change | -4.33% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$0.39
Latest analyst target
3. DCF / Fair value
$0.76
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.39
Low
—
High
—
Mean
—
- Here’s Why Mangoceuticals Stock (MGRX) Rocketed Today - TipRanks Fri, 20 Feb 2026 08
- Telehealth wellness brand MangoRx pulls in $2.5M from investors - Stock Titan hu, 18 Dec 2025 08
- $MGRX stock is down 20% today. Here's what we see in our data. - Quiver Quantitative Fri, 19 Dec 2025 08
- Stop Loss: Is MGRX stock risky to hold now - Watch List & Reliable Entry Point Trade Alerts - baoquankhu1.vn ue, 17 Mar 2026 02
- Market Movers | Winners: ADVB, MGRX, CETY | Losers: ROC, VEEE, GRAL - Trefis Fri, 20 Feb 2026 08
- Mangoceuticals plunges after denying Lilly, Novo partnerships - Seeking Alpha Fri, 14 Nov 2025 08
- Mangoceuticals stock surges on TRT program growth - Investing.com Fri, 20 Feb 2026 08
- Why is MGRX Soaring? Find Out Now! - StocksToTrade hu, 13 Nov 2025 08
- Why a wellness company is rolling out a $100M Solana crypto treasury - Stock Titan Fri, 19 Dec 2025 08
- MGRX PE Ratio & Valuation, Is MGRX Overvalued - Intellectia AI Sat, 07 Mar 2026 22
- Mangoceuticals secures $2.5 million through registered direct offering - Investing.com hu, 18 Dec 2025 08
- Lilly, Novo in pact with Mangoceuticals for direct sales of weight loss drugs - Seeking Alpha hu, 13 Nov 2025 08
- Mangoceuticals Inc. (MGRX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade hu, 13 Nov 2025 15
- Zero respiratory deaths in 29,000 birds sparks global patent bid - Stock Titan Fri, 06 Mar 2026 08
- $99 testosterone injections give MangoRx a 336% sales surge - Stock Titan hu, 19 Feb 2026 08
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 3333 | 3884.0 | — | Sale at price 1.17 per share. | JOHNSTON EUGENE M | Chief Financial Officer | — | 2025-12-15 00:00:00 | D |
| 1 | 5000 | 5975.0 | — | Sale at price 1.20 per share. | JOHNSTON EUGENE M | Chief Financial Officer | — | 2025-12-09 00:00:00 | D |
| 2 | 10000 | 11280.0 | — | Sale at price 1.13 per share. | JOHNSTON EUGENE M | Chief Financial Officer | — | 2025-12-05 00:00:00 | D |
| 3 | 125000 | 152875.0 | — | Sale at price 1.22 per share. | HAMILTON ALEX P | Director | — | 2025-11-19 00:00:00 | D |
| 4 | 100000 | — | — | Stock Award(Grant) at price 0.00 per share. | JOHNSTON EUGENE M | Chief Financial Officer | — | 2025-09-09 00:00:00 | D |
| 5 | 100000 | — | — | Stock Award(Grant) at price 0.00 per share. | MYERS KENNY | Director | — | 2025-09-09 00:00:00 | D |
| 6 | 100000 | — | — | Stock Award(Grant) at price 0.00 per share. | D'ALESSIO LORRAINE PAMELA | Director | — | 2025-09-09 00:00:00 | D |
| 7 | 100000 | — | — | Stock Award(Grant) at price 0.00 per share. | HAMILTON ALEX P | Director | — | 2025-09-09 00:00:00 | D |
| 8 | 25000 | — | — | Stock Award(Grant) at price 0.00 per share. | JOHNSTON EUGENE M | Chief Financial Officer | — | 2024-11-11 00:00:00 | D |
| 9 | 800000 | nan | — | — | COHEN JACOB D. | Chief Executive Officer | — | 2024-08-26 00:00:00 | I |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.00 | 0.00 | 0.00 |
| NormalizedEBITDA | -7.90M | -9.13M | -1.99M |
| NetIncomeFromContinuingOperationNetMinorityInterest | -8.71M | -9.21M | -2.00M |
| ReconciledDepreciation | 791.24K | 79.87K | 3.86K |
| ReconciledCostOfRevenue | 166.20K | 220.12K | 4.09K |
| EBITDA | -7.90M | -9.13M | -1.99M |
| EBIT | -8.69M | -9.21M | -1.99M |
| NetInterestIncome | -13.70K | 0.00 | -6.47K |
| InterestExpense | 13.70K | 0.00 | 6.47K |
| NormalizedIncome | -8.71M | -9.21M | -2.00M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -8.71M | -9.21M | -2.00M |
| TotalExpenses | 9.31M | 9.95M | 2.00M |
| TotalOperatingIncomeAsReported | -7.97M | -9.22M | -1.99M |
| DilutedAverageShares | 1.98M | 1.07M | 1.02M |
| BasicAverageShares | 1.98M | 1.07M | 1.02M |
| DilutedEPS | -4.84 | -8.58 | -1.96 |
| BasicEPS | -4.84 | -8.58 | -1.96 |
| DilutedNIAvailtoComStockholders | -8.71M | -9.21M | -2.00M |
| NetIncomeCommonStockholders | -8.71M | -9.21M | -2.00M |
| NetIncome | -8.71M | -9.21M | -2.00M |
| MinorityInterests | 1.08K | 0.00 | |
| NetIncomeIncludingNoncontrollingInterests | -8.71M | -9.21M | -2.00M |
| NetIncomeContinuousOperations | -8.71M | -9.21M | -2.00M |
| TaxProvision | 0.00 | 0.00 | 0.00 |
| PretaxIncome | -8.71M | -9.21M | -2.00M |
| OtherIncomeExpense | 6.47K | ||
| OtherNonOperatingIncomeExpenses | 6.47K | ||
| NetNonOperatingInterestIncomeExpense | -13.70K | 0.00 | -6.47K |
| InterestExpenseNonOperating | 13.70K | 0.00 | 6.47K |
| OperatingIncome | -8.69M | -9.22M | -1.99M |
| OperatingExpense | 9.07M | 9.65M | 2.00M |
| OtherOperatingExpenses | 453.75K | 1.10M | |
| DepreciationAmortizationDepletionIncomeStatement | 721.53K | 0.00 | |
| DepreciationAndAmortizationInIncomeStatement | 721.53K | 0.00 | |
| Amortization | 721.53K | 0.00 | |
| AmortizationOfIntangiblesIncomeStatement | 721.53K | 0.00 | |
| SellingGeneralAndAdministration | 7.90M | 8.55M | 2.00M |
| SellingAndMarketingExpense | 1.48M | 2.10M | 352.86K |
| GeneralAndAdministrativeExpense | 6.42M | 6.45M | 1.64M |
| OtherGandA | 3.00M | 3.32M | 1.64M |
| SalariesAndWages | 3.42M | 3.13M | 0.00 |
| GrossProfit | 379.96K | 431.50K | 4.85K |
| CostOfRevenue | 235.91K | 299.99K | 4.09K |
| TotalRevenue | 615.87K | 731.49K | 8.94K |
| OperatingRevenue | 615.87K | 731.49K | 8.94K |
| Line Item | 2023-12-31 | |||
|---|---|---|---|---|
| TreasurySharesNumber | 0.00 | |||
| OrdinarySharesNumber | 3.25M | 1.43M | 1.02M | 1.02M |
| ShareIssued | 3.25M | 1.43M | 1.02M | 1.02M |
| NetDebt | 91.35K | 16.72K | ||
| TotalDebt | 214.96K | 128.68K | 352.87K | 39.27K |
| TangibleBookValue | -1.29M | 774.75K | 614.03K | -16.72K |
| InvestedCapital | 14.10M | 774.75K | 781.49K | 22.55K |
| WorkingCapital | -1.35M | 624.32K | 434.03K | -16.72K |
| NetTangibleAssets | -1.29M | 774.75K | 614.03K | -16.72K |
| CapitalLeaseObligations | 64.96K | 128.68K | 185.41K | 0.00 |
| CommonStockEquity | 13.95M | 774.75K | 614.03K | -16.72K |
| PreferredStockEquity | 98.00 | |||
| TotalCapitalization | 13.95M | 774.75K | 614.03K | -16.72K |
| TotalEquityGrossMinorityInterest | 13.95M | 774.75K | 614.03K | -16.72K |
| MinorityInterest | -1.08K | 0.00 | ||
| StockholdersEquity | 13.95M | 774.75K | 614.03K | -16.72K |
| OtherEquityInterest | -825.71K | |||
| GainsLossesNotAffectingRetainedEarnings | -9.85K | 0.00 | ||
| OtherEquityAdjustments | -9.85K | |||
| RetainedEarnings | -20.81M | -11.23M | -2.02M | -17.70K |
| AdditionalPaidInCapital | 35.59M | 12.00M | 2.63M | 181.00 |
| CapitalStock | 423.00 | 148.00 | 1.34K | 800.00 |
| CommonStock | 325.00 | 148.00 | 1.34K | 800.00 |
| PreferredStock | 98.00 | 0.00 | ||
| TotalLiabilitiesNetMinorityInterest | 1.43M | 276.04K | 389.26K | 39.27K |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 0.00 | 64.96K | 128.68K | 0.00 |
| LongTermDebtAndCapitalLeaseObligation | 0.00 | 64.96K | 128.68K | 0.00 |
| LongTermCapitalLeaseObligation | 0.00 | 64.96K | 128.68K | 0.00 |
| CurrentLiabilities | 1.43M | 211.08K | 260.58K | 39.27K |
| CurrentDebtAndCapitalLeaseObligation | 214.96K | 63.72K | 224.19K | 39.27K |
| CurrentCapitalLeaseObligation | 64.96K | 63.72K | 56.73K | 0.00 |
| CurrentDebt | 150.00K | 167.46K | 39.27K | |
| CurrentNotesPayable | 150.00K | 0.00 | 167.46K | 39.27K |
| PayablesAndAccruedExpenses | 1.21M | 147.36K | 36.39K | 0.00 |
| Payables | 1.21M | 147.36K | 36.39K | |
| OtherPayable | 373.00K | |||
| TotalTaxPayable | 0.00 | 6.59K | 2.72K | 0.00 |
| AccountsPayable | 837.50K | 140.76K | 33.67K | |
| TotalAssets | 15.37M | 1.05M | 1.00M | 22.55K |
| TotalNonCurrentAssets | 15.29M | 215.39K | 308.68K | 0.00 |
| NonCurrentPrepaidAssets | 16.94K | 16.94K | 0.00 | |
| GoodwillAndOtherIntangibleAssets | 15.23M | 0.00 | ||
| OtherIntangibleAssets | 15.23M | |||
| NetPPE | 62.30K | 215.39K | 291.74K | 0.00 |
| AccumulatedDepreciation | -2.26K | -28.75K | -3.86K | 0.00 |
| GrossPPE | 64.56K | 244.14K | 295.60K | 0.00 |
| OtherProperties | 59.49K | 239.08K | 290.54K | |
| MachineryFurnitureEquipment | 5.06K | 5.06K | 5.06K | 0.00 |
| CurrentAssets | 75.59K | 835.40K | 694.61K | 22.55K |
| PrepaidAssets | 16.94K | 77.89K | 11.74K | 0.00 |
| Inventory | 0.00 | 18.50K | 0.00 | |
| FinishedGoods | 0.00 | 18.50K | ||
| CashCashEquivalentsAndShortTermInvestments | 58.65K | 739.01K | 682.86K | 22.55K |
| CashAndCashEquivalents | 58.65K | 739.01K | 682.86K | 22.55K |
| CashFinancial | 58.65K | 739.01K |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
| FreeCashFlow | -4.86M | -7.00M | -1.39M |
| RepaymentOfDebt | 0.00 | -167.46K | -25.07K |
| IssuanceOfDebt | 150.00K | 0.00 | 75.00K |
| IssuanceOfCapitalStock | 3.98M | 6.20M | 2.00M |
| CapitalExpenditure | -3.52K | -43.10K | |
| InterestPaidSupplementalData | 0.00 | 0.00 | 0.00 |
| IncomeTaxPaidSupplementalData | 0.00 | 0.00 | 0.00 |
| EndCashPosition | 58.65K | 739.01K | 682.86K |
| BeginningCashPosition | 739.01K | 682.86K | 22.55K |
| EffectOfExchangeRateChanges | -9.85K | 0.00 | |
| ChangesInCash | -670.51K | 56.15K | 660.31K |
| FinancingCashFlow | 4.13M | 7.06M | 2.05M |
| CashFlowFromContinuingFinancingActivities | 4.13M | 7.06M | 2.05M |
| ProceedsFromStockOptionExercised | 0.00 | 1.02M | 0.00 |
| NetPreferredStockIssuance | 2.65M | 0.00 | |
| PreferredStockIssuance | 2.65M | 0.00 | |
| NetCommonStockIssuance | 1.33M | 6.20M | 2.00M |
| CommonStockIssuance | 1.33M | 6.20M | 2.00M |
| NetIssuancePaymentsOfDebt | 150.00K | -167.46K | 49.93K |
| NetShortTermDebtIssuance | 150.00K | -167.46K | 49.93K |
| ShortTermDebtPayments | 0.00 | -167.46K | -25.07K |
| ShortTermDebtIssuance | 150.00K | 0.00 | 75.00K |
| InvestingCashFlow | 65.00K | -3.52K | -43.10K |
| CashFlowFromContinuingInvestingActivities | 65.00K | -3.52K | -43.10K |
| NetOtherInvestingChanges | 65.00K | ||
| NetPPEPurchaseAndSale | 0.00 | -3.52K | -43.10K |
| PurchaseOfPPE | 0.00 | -3.52K | -43.10K |
| OperatingCashFlow | -4.86M | -7.00M | -1.35M |
| CashFlowFromContinuingOperatingActivities | -4.86M | -7.00M | -1.35M |
| ChangeInWorkingCapital | 660.38K | -13.47K | 18.87K |
| ChangeInOtherCurrentLiabilities | -90.72K | -56.73K | 185.41K |
| ChangeInPayablesAndAccruedExpense | 690.14K | 110.97K | 36.39K |
| ChangeInPayable | 690.14K | 110.97K | 36.39K |
| ChangeInAccountPayable | 696.74K | 107.09K | 33.67K |
| ChangeInTaxPayable | -6.59K | 3.88K | 2.72K |
| ChangeInIncomeTaxPayable | -6.59K | 3.88K | 2.72K |
| ChangeInPrepaidAssets | 60.95K | -49.21K | -28.69K |
| ChangeInInventory | 0.00 | -18.50K | 0.00 |
| ChangeInReceivables | 54.98K | -174.24K | |
| OtherNonCashItems | 2.11M | 1.52M | 546.54K |
| StockBasedCompensation | 248.68K | 624.46K | 234.09K |
| AssetImpairmentCharge | 18.50K | 0.00 | |
| DepreciationAmortizationDepletion | 791.24K | 79.87K | 3.86K |
| DepreciationAndAmortization | 791.24K | 79.87K | 3.86K |
| AmortizationCashFlow | 781.30K | 54.98K | |
| AmortizationOfIntangibles | 781.30K | 54.98K | |
| Depreciation | 9.94K | 24.89K | 3.86K |
| OperatingGainsLosses | 18.39K | -151.82K | |
| GainLossOnInvestmentSecurities | -151.82K | ||
| NetIncomeFromContinuingOperations | -8.71M | -9.21M | -2.00M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for MGRX
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|